The heart and estrogen/progestin replacement study (HERS). (Q33544850)

27 July 2017

1 reference

title

The heart and estrogen/progestin replacement study (HERS). (English)

1 reference

27 July 2017

Speroff L

1

1 reference

27 July 2017

publication date

1 November 1998

1 reference

27 July 2017

1 reference

27 July 2017

volume

31

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

9-14

1 reference

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Prior to use of estrogen replacement therapy, are users healthier than nonusers?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Decreased mortality in users of estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Prior and current health characteristics of postmenopausal estrogen replacement therapy users compared with nonusers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Hormone replacement therapy: prevalence, compliance and the 'healthy women' notion

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Estrogen replacement therapy and prognosis after first myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Effect on survival of estrogen replacement therapy after coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Estrogen replacement therapy after coronary angioplasty in women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Current estrogen-progestin and estrogen replacement therapy in elderly women: association with carotid atherosclerosis. CHS Collaborative Research Group. Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

EFFECTS OF OESTROGEN AND PROGESTERONE ON AGE-RELATED CHANGES IN ARTERIES OF POSTMENOPAUSAL WOMEN

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Carotid plaque regression on oestrogen replacement: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Oral contraceptives and arterial and venous thrombosis: a clinician's formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Hemostatic factors according to menopausal status and use of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Fibrinogen and plasminogen modifications during oral estradiol replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Short- and long-term effects of hormone replacement therapy (transdermal estradiol vs oral conjugated equine estrogens, combined with medroxyprogesterone acetate) on blood coagulation factors in posimenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Thrombosis and hormone replacement therapy in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Coagulation activation following estrogen administration to postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Estrogen replacement therapy and coagulation: relationship to lipid and lipoprotein changes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Effect of estrogen-progestin hormonal replacement therapy on plasma antithrombin III of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Conjugated equine estrogens alone, but not in combination with medroxyprogesterone acetate, inhibit aortic connective tissue remodeling after plasma lipid lowering in female monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Cause-specific mortality in women receiving hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

Postmenopausal hormone therapy and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900104-2

7 January 2021

10.1016/S0378-5122(98)00104-2

Identifiers

DOI

1 reference

27 July 2017

1 reference